TFA Therapeutics, Inc. (RAJAF) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $484.6K | +39.7% |
| 2024 | $347.0K | +198.8% |
| 2023 | $116.1K | +744.9% |
| 2022 | $13.7K | -98.7% |
| 2021 | $1.06M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $484.6K | +39.7% |
| 2024 | $347.0K | +198.8% |
| 2023 | $116.1K | +744.9% |
| 2022 | $13.7K | -98.7% |
| 2021 | $1.06M | — |